Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-04
1995-05-02
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514319, 514327, 514329, 544130, 546205, 546217, 546223, 546224, A61K 31445, C07D41312, C07D40112, C07D21158
Patent
active
054119715
ABSTRACT:
The invention relates to N-alkylenepiperidino compounds of formula ##STR1## as well as their enantiomers, and pharmaceutical compositions containing them that are useful as antagonists of neurokinin receptors in the treatment of substance P- and/or neurokinin-independent pathologies.
REFERENCES:
patent: 3998834 (1976-12-01), Janssen et al.
patent: 4134982 (1979-01-01), Wise et al.
patent: 4179569 (1979-12-01), Janssen et al.
patent: 4246267 (1981-01-01), Vincent et al.
Broeck Didier Van
Edmonds-Alt Xavier
Martinez Serge
Proietto Vincenzo
Elf Sanofi
Henley III Raymond
Spivack Phyllis G.
LandOfFree
N-alkylenepiperidino compounds, their enantiomers and pharmaceut does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-alkylenepiperidino compounds, their enantiomers and pharmaceut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkylenepiperidino compounds, their enantiomers and pharmaceut will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137285